logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • IPG PHARMACEUTICALS, INC. drugs

    FiltersReset Filters
    10 results

    • carbzah - carbinoxamine maleate solution

      (Carbinoxamine Maleate)
      Ipg Pharmaceuticals, Inc.

    • clemsza - clemastine fumarate tablet

      (Clemastine Fumarate)
      Ipg Pharmaceuticals, Inc.

    • clobetasol propionate

      (clobetasol propionate)
      IPG PHARMACEUTICALS, INC.
      Usage: Clobetasol propionate cream is indicated for relieving inflammatory and itchy symptoms of corticosteroid-responsive skin conditions. It should not be used for more than 2 weeks or exceed 50 g per week, especially in pediatric patients under 12, due to potential HPA axis suppression.

    • diclofenac sodium

      (diclofenac sodium)
      IPG PHARMACEUTICALS, INC.
      Usage: Diclofenac sodium topical solution is indicated for the treatment of signs and symptoms associated with osteoarthritis of the knees.

    • diclofenac sodium

      (diclofenac sodium)
      IPG PHARMACEUTICALS, INC.
      Usage: Diclofenac Sodium Gel is indicated for the topical treatment of actinic keratoses (AK). Patients should avoid sun exposure during therapy.

    • fluocinonide

      (Fluocinonide)
      IPG PHARMACEUTICALS, INC.
      Usage: Fluocinonide Cream USP, 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

    • fluocinonide

      (Fluocinonide)
      IPG PHARMACEUTICALS, INC.
      Usage: Fluocinonide Topical Solution USP, 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

    • fluocinonide

      (Fluocinonide)
      IPG PHARMACEUTICALS, INC.
      Usage: Fluocinonide cream USP, 0.1% is indicated for relieving inflammatory and pruritic symptoms of corticosteroid-responsive dermatoses in patients aged 12 and older. Treatment should not exceed 2 consecutive weeks or 60 g per week. It is not recommended for rosacea, perioral dermatitis, or use on the face, groin, or axillae.

    • flurbiprofen - flurbiprofen tablet

      (Flurbiprofen)
      Ipg Pharmaceuticals, Inc.

    • lurbiro - flurbiprofen tablet

      (Flurbiprofen)
      Ipg Pharmaceuticals, Inc.